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ABSTRACT  
The base-induced propargylation of the dye, indigo, results in the rapid and unprecedented one-pot 
synthesis of highly functionalised representatives of the pyrazino[1,2-a:4,3-a´]diindole, pyrido[1,2-
a:3,4-b´]diindole and benzo[b]indolo[1,2-h]naphthyridine heterocyclic systems, the last two reflecting 
the core skeleton of the anti-cancer / anti-plasmodial marine natural products, fascaplysin and 
homofascaplysins and a ring B-homolog respectively. The polycyclic compounds 6 - 8, whose 
structures were confirmed through single crystal X-ray crystallographic analysis, arise from sequential 
inter/intramolecular substitution-addition reactions, and in some cases, ring rearrangement reactions. 
Preliminary studies on controlling the reaction path selectivity, and the potential reaction mechanisms, 
are also described. Initial biological activity studies with these new heterocyclic derivatives indicated 
promising in vitro anti-plasmodial activity as well as good anti-cancer activity. The chemistry described 
is new for the indigo moiety and cascade reactions from this readily available and cheap starting 
material should be applicable more broadly in the synthesis of additional new heterocyclic systems 
difficult to access by other means. 
INTRODUCTION 
One of the current goals in organic synthesis is the controlled construction of complex molecules, in 
particular, through the use of cascade reaction sequences.1 Such molecular explorations, yielding novel 
architectures, is of particular interest for the investigation of new bioactive agents with possible new 
modes of action, which could be subsequently elaborated in medicinal chemistry programs.2 
Approaches to the realization of these synthetic goals have often been explored in the context of 
complex multistep syntheses of natural product targets.3 Our focus has been on the smaller, though 
versatile canvas, of the abundant and cheap natural product, indigo 1 (Scheme 1). 
There is significant advantage in starting with a readily available advanced precursor like indigo: its 
reported chemistry is very limited despite the presence of an array of closely positioned functionality in 
the 2,2´-diindolic unit which allows for cascade reaction paths. It also provides a unique opportunity in 
providing an advanced starting material for the potential rapid synthesis of the diindolic system of 
natural products analogs. Such biologically active natural products (e.g. with anti-cancer or 
antimicrobial activity) include fascaplysin4; homofascaplysin5; iheyamines6; staurosporine7 and 
rebeccamycin8 (Figure 1). 
 
Figure 1. Some biologically active natural products with an embedded 2,2´-diindolic unit. 
 
To explore our synthetic approach, we initially investigated the base-mediated reactions of indigo with 
allylic halides, which in the case of allylic bromide resulted in the rapid synthesis of the multicyclic 
compounds 2 and 3 (Scheme 1).9 These compounds represent new ring systems with functionality 
suitable for further elaboration of molecular complexity. 
In an extension of this work and in an investigation of reaction directing elements, particularly those 
modulating nucleophilic-electrophilic reactivities, we have studied the base induced reactions of indigo 
with the simple alkyne analog, propargyl bromide. New facile routes to the core heterocyclic system of 
fascaplysin, homofascaplysin and the B-ring homolog of this system were discovered and the results 




Scheme 1. Allylation of indigo 
RESULTS AND DISCUSSION 
Synthesis and Structural Elucidation 
Our previous experience in the chemistry of indigo9 revealed that relatively small changes to reaction 
conditions could have major impacts on the product outcome. Therefore, our attempts at the 
propargylation of indigo paid particular attention to stringent and repeatable reactions conditions. In 
this context, a solution of indigo in DMF was generated through sonication for 30 mins at room 
temperature and then transferred to a septum-equipped flask which contained pre-dried molecular 
sieves and cesium carbonate under an inert atmosphere. The flask was then plunged into a preheated 
oil-bath (strictly 85-87 °C) and stirred for 30 mins, followed by the addition of propargyl bromide and 
the reaction mixture heated at this temperature for 5 mins. Following quenching, a sequence of 
separations yielded the five new products 4 - 8 in a combined yield of 81% (Scheme 2). 
 
Scheme 2. Base-mediated propargylation of indigo to produce the heterocyclic compounds 4 - 8. 
Adjacent to each structure is illustrated a solution, highlighting the color.  
 
The expected mono N-substituted indigo derivative (4) was isolated as a deep blue, papery solid in 11% 
yield after silica-gel column chromatography. Data from the HRESI mass spectrum was consistent with 
the molecular formula of 4 and was indicative of the addition of one propargyl unit. 1H NMR NOE 
analysis also confirmed the presence of the expected trans isomer. In a separate reaction, under 
analogous conditions but with a very short reaction time (<1 min) and a stoichiometric quantity of 
propargyl bromide, compound 4 could be isolated in a much improved 93% yield (Scheme 3, Step A). 
The increased solubility in a range of organic solvents (e.g. THF, CH2Cl2) enables this 
monopropargylated material to be used as a starting material for subsequent reactions, including 
cyclisations. This increased flexibility in the use of solvents allows for a greater variation in reaction 
conditions to be used. 
 
Scheme 3. Synthesis of 4 and subsequent conversion to 5 
 
The pyrazinodiindole 5 (Scheme 2) was isolated in 21% yield as a red-burgundy solid. The 1H NMR 
spectrum showed singlets at 5.04 and 5.38 ppm, assigned to the exocyclic methylene protons whereas 
the 13C NMR spectrum showed 2 peaks at 179.7 and 180.8 ppm, assigned to two non-equivalent 
carbonyls. Data from the HRESI mass spectrum was supportive of the molecular formula of 5 and was 
indicative of the addition of one propargyl unit. 
The UV-vis spectrum of 5 had a strong adsorption band with a maximum at 324 nm (ε = 13,088). The 
burgundy color was suggestive that the central double bond of indigo remained intact, with all other 
indigo derivatives in which this bond had been converted to a single bond appearing as yellow 
compounds. Simple modelling studies (Spartan, Wavefunction) indicated that compound 5, while 
planar through the indigo moiety, positioned the hydrogen atoms of the endocyclic methylene group 
above and below the plane of the molecule with the exocyclic methylene twisted out of the molecule 
plane.10 This product 5 can also be synthesized in high yield (98%) by the reaction of 4 in DMF in the 
presence of Cs2CO3 (Scheme 3, Step B). 
The pyridodiindole 6 (Scheme 2) was isolated in 17% yield as yellow-orange crystals. Analysis of the 
1H NMR indicated a peak at 9.62 ppm assigned to the aldehyde proton, and a doublet at 4.79 ppm (J = 
6.5 Hz) assigned to the terminal protons of the allene moiety and a singlet at 2.33 assigned to the 
terminal alkyne proton. The 13C NMR spectrum showed peaks at 90.4, 208.4 and 80.4 ppm, assigned 
sequentially to the three allene carbons from the CH. A peak at 195.7 ppm was assigned to the 
aldehyde. The HRESI mass spectrum of 6 was consistent with a molecular formula of C25H16N2O2. The 
molecular structure was confirmed as 6 by X-ray crystallographic analysis, together with the 
disposition of the allene group over the pyrido ring rather than pointing away from it (Scheme 2). There 
is one stereogenic carbon present at C12a, but in the absence of any chiral element during the reaction, 
the stereochemical outcome was a racemic mixture, as confirmed by optical rotation analysis. The 
structure of 6 poses interesting mechanistic questions. The addition of three propargyl units is 
evidenced by the presence of the allene, the N-propargyl unit and the three carbon moiety 
encompassing the aldehyde, and C6 and C7. Interestingly, this three carbon unit is attached to the 
indigoyl N at the middle carbon, and not through the propargyl bromide methylene or the terminal 
alkynic positions. 
The major product of the reaction was the benzoindolonaphthyridinone 7 (scheme 2) isolated in 31% 
yield as a yellow solid which was also highly fluorescent in CH2Cl2 solution with a brilliant yellow 
color under UV light (365 nm). The 1H NMR showed two pairs of doublets at 8.01 and 7.33 ppm (J = 
7.4 Hz) assigned to H6 and H7 respectively. Two singlets at 2.14 and 2.30 ppm were assigned to the 
terminal acetylenic protons with the corresponding propargyl methylenes assigned to the doublets at 
4.74 and 5.49 ppm (J = 2.4 Hz). A comparative analysis of the NMR and mass spectra indicated that 
although two substituent propargyl units were present, the molecular ion indicated the addition of three 
propargyl units, the last being incorporated into a ring (Scheme 2, 7, blue). The structure of 7 was 
confirmed by X-ray crystallographic analysis. The ring expansion of the indigo 5-membered ring into a 
6-membered ring is new chemistry, with the three additional carbons of the indolo[1,2-
h][1,7]naphthyridine parent structure being sourced from the additional propargyl unit. 
Retrosynthetically, sourcing the C6-C7-C7a moiety from a propargyl unit with the remaining skeleton 
from indigo isn’t intuitive and highlights the novelty of this new chemistry of indigo. The final product, 
isolated in very low yield (1%), was the yellow benzoindolonaphthyridinone 8 (Scheme 2), with the 
structure confirmed by single-crystal X-ray analysis. 
Color is an important qualitative element in the structural elucidation of these polycyclic compounds. 
The disappearance of the blue and emergence of yellow appears to indicate the loss of H-bonding 
between the indigo carbonyl and the NH, along with loss of unsaturation in the indigo central bond and 
the presence of either sp3 hybridised carbon atoms (e.g. 6), or extended fused ring systems e.g. 
heterocycles 7 or 8. The mono-N-propargylated 4, with both structural elements still present, maintains 
the deep blue intensity whereas the cyclized structure 5, which still contains the central double bond 
but has lost the H-bonding, is a burgundy color (Scheme 2). 
Mechanistic and Reaction Discussion 
The proposed mechanisms for the propargylation of indigo are summarised in Schemes 4-6 and involve 
five key pathways. The pyrazinodiindole 5 is derived from the monopropargylated indigo 4 (blue, Path 
I, Scheme 4, and Scheme 3) after N-deprotonation, followed by delocalisation allowing rotation around 
the central bond to the cisoid conformation. Subsequent intramolecular nucleophilic addition to the 
propargyl C2 position yields 5 (Scheme 4).  
 
Scheme 4. Proposed mechanism for formation of 4 and 5. Structures that are colored indicate common 
intermediates in the overall mechanism and are the same within Schemes 5 and 6. 
 
Path II starts with the identical key intermediate 4 (blue, Scheme 5) undergoing prototropic 
tautomerism (A) which subsequently N-alkylates (B). Deprotonation of the N-methylene generates a 
stabilised ylid, which allows cyclisation onto the carbonyl generating an activated cyclic allene 
intermediate (C). Under standard conditions, an ‘alkyne nucleophile’ is insufficiently strong to attack 
an electrophilic carbonyl in the absence of a metal (e.g. Au, Ru) or an activating influence. In this 
instance, the anion from the ylid serves as a formal negative charge allowing this cyclisation to the 7-
ring allene to occur. A comprehensive review on allenes from 198911 reported the isolation of an eight-
membered carbocyclic allene, however, the corresponding six-membered rings have been plausibly 
demonstrated as reactive intermediates.12 Further, with the seven-membered carbocyclic allene, 
isodesmic reaction energy calculations indicate13 an allene strain component of 13.5 - 14.3 kcal/mol, 
consistent with its ready preparation and trapping. Heterocyclic allenes have also been isolated as small 
as eight-membered rings, with a mixed ‘P’ and ‘B’ heteroatom ylid.14 Therefore the postulated cyclic 
allene intermediate C (Scheme 5) is reasonable. 
The cyclic allene could then undergo a ring-expansion reaction, to produce the benzo[b]indolo[1,2-
h][1,7]naphthyridin-8-(13H)-one ring structure D (Scheme 5). The proposed driving force behind this 
ring-expansion is relief of ring strain of the 7-membered allenic ring - therefore, there is a favourable 
energy balance between the 7-membered allenic ring formation, and its subsequent role in providing a 
driving force for ring expansion. An additional crucial component of this step is the presence of an 
electrophile (E) - the major product arising from the reaction, 7, requires E = H+, whereas the minor 
product 8 requires E = CO2, probably generated, on the basis of the results noted in Table 1, from 
carbonic acid decomposition, the acid in turn resulting ultimately from the Cs2CO3 base via bicarbonate 
(see below for a greater discussion). Once the carboxylate unit is incorporated, a further propargyl 
moiety could be added via nucleophilic displacement to produce the ester substituent of 8. Subsequent 
dehydrogenation, followed by base-induced aromatisation allows for O-propargylation in a cascade 
process, yielding the final products 7 (Path III) and 8 (Path IV)(Scheme 5). 
 
 
Scheme 5. Proposed mechanism for formation of 7 and 8.  
The addition of a 1-carbon unit is novel and imposes the question as to the origin of this carbon, even 
though 8 is isolated in very low yield. Two possibilities arise and involve either the well-known 
degradation of DMF15 to produce a “C=O” fragment that could be incorporated, or it could arise from 
the generated bicarbonate anion that is present in the solution. Table 1 summarizes experiments to 
determine the source of the additional carbon atom in 8. Entry 1 is the standard reaction as previously 
outlined, whereas entry 2 describes replacing the DMF solvent with DMSO - this resulted in an 
increase from <1% to a 5% yield suggesting that DMF was not the source of the carboxylate of 8. 
Bubbling CO2 gas through a standard reaction (entry 3) resulted in a 6% yield of 8, however, the most 
significant outcome from this reaction is the notably reduced yields of 4, 5, 6 and 7, and a dramatic 
increase in the production of non-characterisable baseline material. This suggests that the presence of 
significant quantities of electrophiles could be reacting with different indigo-based nucleophiles as they 
are being generated resulting in mixtures of products. Entry 4 describes the experiment replacing the 
Cs2CO3 with K3PO4 as base, to eliminate the presence of a bicarbonate source. However, the lack of 
solubility of this base in DMF is the likely reason for the outcome of mostly unreacted indigo being 
isolated from the reaction. 

























1 DMF Cs2CO3, N2 11 21 17 31 1 11 - 
2 DMSO Cs2CO3, N2 - - 12 13 5 65 - 
3 DMF Cs2CO3, CO2 13 - 7 10 6 61 - 
4 DMF K3PO4, N2 21 - - - - - 60 
5 DMF Cs2CO3, Ar 10 15 14 28 1 * - 
* not isolated 
Path V (Scheme 6) describes a possible mechanism to the allene 6 and diverges from the same 
intermediate B (red, Scheme 5). In this instance it is the iminium indigo moiety that activates the 
adjacent carbonyl, allowing sufficient electrophilicity to attract the relatively weak nucleophilic alkyne 
to undergo a cyclisation reaction, promoted by the initial attack of the other indigo nitrogen lone 
electron pair onto the propargyl C2 in a concerted process yielding the strained fused-aziridine E. 
Carbonate could then act as a nucleophile in a ring-opening of the aziridine and subsequent 
aromatisation of the central pyridinyl ring to give F. O-Propargylation of F could then afford 
intermediate G. The acidic proton in the CH2OH group α to the iminium ion in G may then be removed 
under the influence of base and further OH proton loss would yield the aldehyde moiety in the 
intermediate H. A Claisen rearrangement of the propargyloxy group with the indolic C2-C3 bond could 
then give rise to product 6. 
 
Scheme 6. Proposed mechanism for formation of 6.  
 
The outcomes from this propargylation reaction are repeatable and preliminary investigations also 
indicate reliable scalability up to at least double quantities. Further, our mechanistic proposals for the 
formation of 6 - 8 all start from N,N-dipropargylated intermediates, rather than an intermediate that had 
cyclised initially from a N-monopropargylated molecule. In support of this proposal were the outcomes 
from an experiment where a DMF solution of 4 was dripped into a mixture of Cs2CO3 and propargyl 
bromide in DMF over 3 mins before quenching after 2 mins. The result was formation of 5 (<3%), 6 
(11%), 7 (25%) and 8 (<1%) with complete consumption of the starting material. The poor return of 5 
with respect to 6 - 8 suggests that the second N-propargylation is a more competitive reaction than 
cyclisation, and lends support to our proposed dipropargylated compounds as intermediates. 
It is also relevant to compare the mechanistic outcomes of this propargylation reaction with the 
outcomes of the corresponding allylation reaction (Scheme 1).9 Although cyclisation onto the indigo 
carbonyl of the unsaturated moiety occurred in both instances, reaction onto the indigo C2 position to 
form a spiro compound only occurs in the case of the alkene. There was no evidence suggesting an 
equivalent mechanism pathway in the presence of the alkyne. Presumably, the linear alkyne is not able 
to approach the indigo C2 position whereas the ‘bent’ nature of the alkene makes this cyclisation 
reasonable. Further, a significant by-product of the allylation reaction (Scheme 1) was N-allylisatin 
(structure not illustrated), derived by oxidative cleavage of the central indigo double bond. Under 
propargylation conditions, there was no N-propargylisatin present, as evidenced by TLC analysis of the 
reaction mixture against an authentic sample. 
We have also undertaken some simple experiments to ascertain that the reactions are likely to proceed 
through nucleophilic mechanisms rather than through radical-based sequences. Previous studies have 
shown that radical reactions with indigo will proceed exceptionally slowly at room temperature and in 
4 hours at 100 °C in the presence of oxygen and with irradiation.16 In contrast, we have repeated our 
propargylation reaction (as shown in Scheme 2) in the absence of oxygen and light (under argon) with 
these conditions realizing the same product outcome after 5 mins of reaction at 86 °C. Radical reactions 
are unlikely to proceed under these conditions, let alone to produce a total yield of 84% of products in 5 
mins of reaction time. 
The heterocycles 7 and 8 are analogs of the marine natural products fascaplysin and homofascaplysin 
(Figure 2), initially isolated from the sponge Fascaplysinopsis reticulata and noted for its ATP-
competitive inhibitor of Cdk4/D1 (IC50 = 0.35 µM)
3,17 activity. There have been reported syntheses of 
these natural products including the silver catalysed cascade synthesis of their parent compound and 
analogs, with this approach involving the initial intermolecular reaction of two components of similar 
molecular complexity, however, this necessitated the prior synthesis of these two components.18 The B-
ring homolog of fascaplysin has also been synthesised starting from 4(1H-indol-1-yl)butanoic acid in a 
























Figure 2: Representation of compounds 6 and 7 as analogs of fascaplysin/homofascaplysin and 
fascaplysin/homofascaplysin ring B-homolog respectively. 
 
We report here a facile synthesis of the benzoindolo[1,2-h][1,7]naphthyridine (fascaplysin) heterocyclic 
skeleton from indigo in the presence of propargyl bromide and base in a 17% unoptimised yield. This 
provides direct access to this skeleton starting from exceptionally cheap starting materials and reagents, 
and provides a convenient access to this system for further elaboration in structure-activity studies. 
The reaction of indigo with propargyl bromide in the presence of base produces new complex 
heterocycles via a multi-step, one-pot, cascade-type series of reactions. This is new science for the 
indigo moiety and represents an exciting untapped area of heterocyclic chemistry. Our proposed 
mechanisms (Schemes 4 - 6) reveal that at different stages of the cascade reaction, the reactivity of 
different sites on the indigo moiety changes, and additionally, different types of reactivity can occur at 
different times, including sites acting as nucleophiles or electrophiles, with bond breakage leading to 
ring expansion and dehydration (Figure 3). A key element to the reactivity is the ability of the indigo 
heterocycle to tautomerise under different circumstances (e.g. upon generation of the N-centered anion 
with base) to shift reactivity to a different site. This constantly changing reactivity leads to the variety 
of outcomes as demonstrated. Further, this range of different chemistry all occurs in a tight cluster in 
the centre of the indigo structure and this combination of properties is the key to the variety of unusual 
heterocycles that arises. Further, the unexpected outcomes of this initial study not only shows us that 
there is highly unusual and significant chemistry of indigo, but that there is much yet to be explored in 
this area. 
 
Figure 3: Graphical representation of the changing reactivity of the indigo skeleton with sites of 
nucleophilicity, electrophilicity, dehydration and bond breakage illustrated. The degree of reactivity at 
each of these points changes as the molecule(s) progress through the cascade reaction.  
Biological Testing 
As an initial screen for biological activity, compounds 4 to 7 were subjected to in vitro anti-plasmodial 
and anti-cancer testing (Table 2). All four compounds revealed notable anti-plasmodial20 activity 
against a drug resistant strain in the micromolar range, sufficient for all to be considered lead 
compounds for further development. 
 





















1 4 0.33(1.1) 4.79 (15.9) 8.95 (29.8) 16.26 (54.2) 
2 5 0.26 (0.85) 1.88 (6.24) 1.31 (4.36) 1.93 (6.43) 
3 6 3.34 (8.9) 4.79 (12.7) 7.81 (20.7) ^ 








- 1.21 / 0.108 1.04 / 0.674 - 
# drug resistant K1 strain; ^ non-cytotoxic 
More significantly, 4 (anti-plasmodial IC50 0.33 µg/mL, 1.1 µM) and 5 (anti-plasmodial IC50 0.256 
µg/mL, 0.85 µM) are an order of magnitude more potent than compounds 6 and 7. In the case of 4, 
there was also a significant difference between the level of mammalian (Vero) cell toxicity (IC50 16.26 
µg/mL) and anti-plasmodial activity (Table 1). With respect to the activity against cancer cells20, 
compounds 4 - 7 showed notable activity against the NCI-H187 lung cancer and KB-oral cavity cell 
lines. In particular, 7 was equipotent with the positive control ellipticine. Cytotoxicity20 studies were 
particularly interesting for 5 and 6 with the latter being non-cytotoxic to normal mammalian cells but 
the former was toxic to these cells. Clearly, significant medicinal chemistry studies would need to be 
undertaken to decrease the toxicity to normal mammalian cells and increase the required selectivity. 
However, as a random screening process, all these compounds showed activity that could be considered 
as new lead compounds for a variety of targets. 
CONCLUSION 
We have reported here new cascade reactions of indigo via base-mediated propargylation. The resulting 
shifting of reactivity during each step in the process generates, and then propagates, a cascade reaction, 
producing a range of poly-heterocyclic compounds in unprecedented outcomes. Some of these 
compounds also hold promise as leads for the development of new anti-malarial and anti-cancer agents. 
The scope for this reaction currently remains untapped, however, these initial studies suggest that the 
chemistry of indigo has significant potential for further development towards novel polycyclic 
compounds. The exploration of a variety of reaction types, inclusive of cascade processes, using indigo 
as a starting material remains an additional exciting area of synthetic chemistry to investigate. 
Interestingly, the possibility of using indirubin and isoindigo, as indigo analogs, in comparable cascade 
reactions remains unexplored and these starting materials also offer possibilities for the generation of 
new heterocycles in a one-pot process. These studies are currently underway in our laboratories. 
EXPERIMENTAL SECTION 
General Experimental Information 
Reagents and solvents were purchased reagent grade and used without further purification unless 
otherwise stated. All reactions were performed in standard oven dried glassware under a nitrogen 
atmosphere unless otherwise stated. Melting points temperatures are expressed in degrees Celsius (oC) 
and are uncorrected. 1H and 13C NMR spectra (CHCl3) solutions) were recorded at 500 and 125 MHz 
with chemical shifts () reported in parts per million relative to TMS ( = 0 ppm) or CDCl3 ( = 77.0 
ppm) as internal standards. Coupling constants (J) are reported in Hertz (Hz). Multiplicities are 
reported as singlet (s), broad singlet (bs), doublet of doublets (dd) or multiplet (m). Electron impact 
(EI) mass spectra (MS) and electrospray (ESI - single quadrupole) mass spectra have their ion mass to 
charge (m/z) values stated with their relative abundances as a percentage in parentheses. Peaks assigned 
to the molecular ion are denoted by M+ or M + 1. Infrared (IR) spectra were recorded on neat samples. 
UV-Visible spectra were recorded with solutions of samples in CH2Cl2. Images from crystals were 
captured using stereo microscopes. All the images were provided from X-ray quality single crystals. 
Optical rotations were measured in CH2Cl2 solution at 25 °C. Thin Layer Chromatography (TLC) was 
performed using Silica Gel F254 aluminium sheets. Column chromatography was performed under 
gravity using Silica Gel 60 (0.063-0.200 mm). Eluents are in volume to volume (v:v) proportions. 
Solvent extracts or chromatographic fractions were concentrated by rotary evaporation in vacuo. Indigo 
(dye content 95%) was used without further purification. Petroleum spirit had a b.p. range of 40-60 ºC. 
Products from the Propargylation of Indigo 
A suspension of powdered indigo (250 mg, 0.95 mmol) in anhydrous DMF (40 mL) was sonicated for 
30 min and stirred vigorously under N2 overnight. The resulting suspension was added to pre-dried 
anhydrous cesium carbonate (1.20 g, 3.71 mmol) and molecular sieves (4 Å) while being stirred and 
warmed to 80-85 ºC under a N2 atmosphere. After 30 mins propargyl bromide (0.595 mg 5.0 mmol) 
was added and the reaction mixture was heated at 82-85 ºC for 5 min. The mixture was then filtered hot 
and then the solution was concentrated by rotary evaporation and the residue applied to a short plug of 
silica gel/celite (1:1) and washed consecutively with 4 different solvent mixtures, 1: 70:30 
CH2Cl2/petroleum spirit (250 mL) , 2: CH2Cl2, 3: 50:50 CH2Cl2/EtOAc and 4: 95:5 EtOAc/MeOH  
(250 mL). Four fractions were collected from the four different elutions. Fraction 1 was concentrated 
and slowly recrystallised in 9:1 petroleum spirit/EtOAc then filtered to yield 1-(prop-2-yn-1-yl)-[2,2'-
biindolinylidene]-3,3'-dione 4 (33.00 mg 11%) as a blue, papery solid. Rf (7:3 CH2Cl2/petroleum 
spirit) = 0.53, m.p: 267-269 ºC; λmax/nm (ε, M
-1cm-1) 291 (10447), 634 (6381). IR (neat) υmax 3278 (m), 
1605 (s), 1463 (s), 1297 (s), 1066 (s), 1027 (s), 927 (m), 743 (m) cm-1. 1H NMR δ 2.17 (1H, s, H3''), 
5.41 (1H, s, H1''), 6.96 (1H, t, J = 7.1 Hz, H5'), 6.99 (1H, d, J = 8.1 Hz, H7'), 7.09 (1H, t, J = 7.1 Hz, 
H5), 7.22 (1H, d, J = 8.1 Hz, H7), 7.48 (1H, t, J = 7.5 Hz,  H6), 7.60 (1H, t, J = 7.5 Hz, H6'), 7.69 (1H, 
d, J = 7.5 Hz, H4'), 7.77 (1H, d, J = 7.5 Hz, H4) 10.60 (1H, s, H1). 13C NMR (CDCl3) δ 37.1 (C1''), 
72.5 (C3''), 78.4 (C2''), 111.5 (C7'), 111.9 (C7), 120.4 (C3'a), 120.9 (C5'), 121.5 (C5), 122.0 (C2'), 
122.4 (C2), 125.0 (C4'), 125.1 (C4), 126.2 (C3a), 135.9 (C6), 136.4 (C6), 151.8 (C7'a), 152.6 (C7a), 
187.6 (C3), 189.6 (C3'). MS (EI), m/z 300 (100%, M+), 271 (53), 262 (32). HRMS (ESI) [M+H]+ calcd 
for C19H13N2O2 301.0977, found 301.0964.  
The mother liquors from fraction 1 were combined with fraction 2 and then subjected to a silica gel 
column and elution with 7:3 CH2Cl2/petroleum spirit gave 13-oxo-12-(prop-2-yn-1-yl)-12b 
(propa1,2-dien-1-yl)-12b,13-dihydro-12H-pyrido[1,2-a:3,4-b']diindole-6-carbaldehyde 6 as 
yellow-orange crystals (63.92 mg, 17%). X-ray quality crystals were grown through slow 
crystallization from petroleum spirit/EtOAc (5:3). Rf (CH2Cl2) = 0.26, m.p: 229-231 ºC; UV-Vis 
(CH2Cl2) λmax/nm (ε, M
-1cm-1) 386 (12825), 244 (34151). IR (neat) υmax 3278 (m), 1604 (s), 1463 (s), 
1297 (m), 1065 (s), 1027 (s), 1015 (s), 743 (s) cm-1. 1H NMR δ 2.33 (1H, s, H3'), 4.79 (2H, d, J = 6.5 
Hz, H3''), 5.42 (1H, t, J = 6.5 Hz, H1''), 5.51-5.66 (2H, m, H1'), 6.82 (1H, d, J = 8.4 Hz, H11), 6.94 
(1H, t, J = 7.2 Hz, H3), 7.27 (1H, t, J = 7.6 Hz, H2), 7.35 (1H, t, J = 8.0 Hz, H9), 7.49 (1H, t, J = 8.0 
Hz, H8), 7.54 (1H, d, J = 8.4 Hz, H10), 7.64-7.68 (2H, m, H1, H4), 7.65 (1H, s, H7), 9.62 (1H, s, 1'''). 
13C NMR (CDCl3) δ 36.2 (C1'), 71.3 (C12b), 73.6 (C3'), 77.8 (C2'), 80.4 (C3''), 90.4 (C1''), 110.7 
(C7a), 111.1 (C13a), 111.5 (C9), 113.6 (C1), 117.2 (C12a), 118.6 (C11), 121.1 (C3), 122.6 (C8), 124.1 
(C10), 124.5 (C11a), 124.9 (C4), 131.8 (C7), 137.7 (C7b), 138.2 (C4a), 138.5 (C2), 158.6 (C6), 185.3 
(C1'''), 195.7 (C13), 208.4 (C2''). MS (EI) m/z 376 (5, M+), 371 (100%), 298 (24). HRMS (ESI) 
[M+H]+ calcd for C25H17N2O2 377.1298, found 377.1285. 
Fraction 3 was recrystallised from CH2Cl2/petroleum spirit (1:9) giving 13-(prop-2-yn-1-yl)-14-
(prop-2-yn-1-yloxy)benzo[b]indolo[1,2-h][1,7]naphthyridin-8-(13H)-one 7 (116.6 mg, 31%) as 
orange crystals. X-ray quality crystals were grown through slow crystallization from petroleum spirit : 
ethyl acetate (4:3). Rf  (9:1 CH2Cl2/EtOAc) = 0.52, m.p: 218-220 ºC; UV-Vis (CH2Cl2) λmax/nm (ε, M
-
1cm-1) 324 (27663), 441 (10360). IR (neat) υmax 3205 (w), 1588 (m), 1485 (m), 1349 (m), 1260 (m), 
1059 (m), 725 (s) cm-1. 1H NMR δ 2.14 (1H, t, J = 2.4 Hz, H3'), 2.30 (1H, t, J = 2.4 Hz, H3''), 4.74 
(2H, d, J = 2.4 Hz, H1'), 5.49 (2H, d, J = 2.4 Hz, H1''), 7.33 (1H, d, J = 7.4 Hz, H7), 7.45 (3H, m, H1, 
H2, H3), 7.74-7.77 (1H, t, J = 7.8 Hz, H11), 7.85-7.90 (3H, m, H4, H10, H12), 8.01 (1H, d, J = 7.4 Hz, 
H6), 8.71 (1H, dd, J = 8.1, 1.4 Hz, H9). 13C NMR (CDCl3) δ 44.0 (C1''), 63.7 (C1'), 74.5 (C3'), 76.5 
(C3''), 78.5 (C2''), 78.6 (C2'), 104.0 (C7), 110.9 (C3), 117.9 (C7a), 118.6 (C12), 118.9 (C13b), 119.1 
(C10), 119.9 (C6), 121.6 (C4a), 123.3 (C2), 123.9 (2C, C1, C4), 126.4 (C8a), 126.9 (C9), 129.3 
(C14a), 132.6 (C11), 133.2 (C14), 139.1 (C13a), 143.5 (C12a), 175.8 (C8). MS (EI), m/z 376 (6, M+), 
337 (100%), 309 (20), 298 (75). HRMS (ESI) [M+H]+ calcd for C25H17N2O2 377.1285, found 
377.1302.  
The mother liquor from the recrystallisation of 7 was concentrated and then subjected to silica gel 
column chromatography and elution with CH2Cl2/EtOAc (92:8) resulted in prop-2-yn-1-yl 8-oxo-13-
(prop-2-yn-1-yl)-14-(prop-2-yn-1-yloxy)-8,13-dihydrobenzo[b]indolo[1,2h][1,7]naphthyridine-7-
carboxylate 8 (2 mg, >1%) as bright orange crystals. X-ray quality crystals were grown through slow 
crystallization from chloroform. Rf (9:1, CH2Cl2/EtOAc) = 0.59, m.p: 258-260 ºC; IR (neat) υmax 3278 
(m), 2925 (m), 1718 (s), 1595 (s), 1482 (m), 1237 (m), 1062 (m), 964 (m), 749 (s), 643 (s) cm-1. 1H 
NMR δ 2.14 (1H, bs, H3''), 2.30 (1H, bs, H3'''), 2.53 (1H, bs, H3'), 4.76 (2H, d, J = 2.0 Hz, H1''), 5.06 
(2H, d, J = 1.7 Hz, H1'''), 5.43 (2H, d, J = 1.7 Hz, H1'), 7.43-7.50 (3H, m, H1, H2, H3), 7.75 (1H, t, J = 
7.8 Hz, H11), 7.82-7.90 (3H, m, H4, H10, H12), 8.01 (1H, s, H6), 8.48-8.50 (1H, d, J = 7.8, H9). 13C 
NMR (CDCl3) δ 44.1 (C1'''), 53.4 (C1'), 63.5 (C1''), 74.7 (C3'''), 75.1 (C3'), 76.5 (C3''), 77.9 (C2''), 78.1 
(C2'), 78.2 (C2'''), 110.7 (C7a), 110.8 (C7), 112.2 (C3), 115.1 (C13b), 118.1 (C12), 118.7 (C10), 118.8 
(C6), 122.0 (C4a), 123.8 (C2), 124.1 (C1), 124.7 (C4), 126.7 (C8a), 126.8 (C9), 130.0 (C14a), 133.6 
(C11), 134.5 (C14), 139.2 (C13a), 142.9 (C12a), 167.1 (ester C=O) 174.5 (C8). MS (EI), m/z 458 (5, 
M+), 419 (100%), 380 (10), 375 (5), 337 (20), 298 (45). HRMS (ESI) [M+H]+  calcd for C29H19N2O4 
459.1345, found 459.1363. 
Fraction 4 was purified by preparative TLC using CH2Cl2/EtOAc (88:12) as the developing solvent 
and gave 6-methylene-6,7-dihydropyrazino[1,2-a:4,3-a']diindole-13,14-dione 5 was isolated as a 
dark burgundy powder (63 mg, 21%. Rf (8.5:1.5, CH2Cl2/EtOAc) = 0.51, m.p: 280-284 ºC. UV-Vis 
(CH2Cl2) λmax/nm (ε, M
-1cm-1) 324 (13088), 573 (6430). IR (neat) υmax 1701 (m), 1604 (m), 1470 (m), 
1298 (m), 1185 (m), 1122 (s), 742 (s) cm-1. 1H NMR δ 4.41 (2H, s, H7), 5.04 (1H, H1'a), 5.38 (1H, 
H1'b),  6.95-7.00 (2H, m, H9, H11), 7.09 (1H, t, J = 7.4 Hz, H2), 7.48-7.55 (3H, m, H3, H4, H10), 7.73 
(1H, d, J = 7.5 Hz, H12), 7.82 (1H, d, J = 7.5 Hz, H1). 13C NMR (CDCl3) δ 45.9 (C7), 97.9 (C1'), 
109.5 (C12), 112.7 (C4), 121.4 (C13a), 121.8 (C11), 122.7 (C2), 123.0 (C12a), 124.6 (C14a), 125.3 
(C1), 125.5 (C6), 131.6 (C13b), 135.1 (C10), 135.5 (C3), 147.0 (C4a), 150.0 (C8a), 179.7 (C14), 180.8 
(C13). MS (EI), m/z 300 (14), 207 (100%). HRMS (ESI) [M+H]+ calcd for C19H13N2O2 301.0972, 
found 301.0960. 
1-(Prop-2-yn-1-yl)-[2,2'-biindolinylidene]-3,3'-dione (4) 
A suspension of powdered indigo (500 mg, 1.90 mmol) in anhydrous DMF (50 mL) was sonicated for 
60 min and stirred vigorously under N2 overnight. The resulting suspension was added to pre-dried 
anhydrous cesium carbonate (2.4 g, 7.42 mmol) and the mixture was stirred and warmed to 80-85 ºC 
under a N2 atmosphere. After 30 mins propargyl bromide (1.90 mg 10.0 mmol) was added and the 
reaction mixture was heated at 82-85 ºC for 5 seconds. The mixture was then poured into ice water and 
the resulting precipitate was filtered and recrystallised from petroleum spirit/EtOAc (90:10) to furnish 
1-(prop-2-yn-1-yl)-[2,2'-biindolinylidene]-3,3'-dione 4 (279.00 mg 93%) as a blue fluffy solid.  
6-Methylene-6,7-dihydropyrazino[1,2-a:4,3-a']diindole-13,14-dione (5) 
A solution of 6-methylene-6,7-dihydropyrazino[1,2-a:4,3-a']diindole-13,14-dione 4 (100 mg, 0.33 
mmol) in anhydrous DMF (20 mL) was stirred and warmed to 80-85 ºC under a N2 atmosphere for 20 
min and the solution was then added to pre-dried anhydrous cesium carbonate (107 mg, 0.33 mmol) 
and was stirred and warmed at 80-85 ºC under a N2 atmosphere for 10 min. The mixture was then 
poured into ice water and the resulting precipitate separated and subjected to silica gel short column 
chromatography of and eluted with CH2Cl2/EtOAc (85:15) to give 6-methylene-6,7-
dihydropyrazino[1,2-a:4,3-a']diindole-13,14-dione 5 as a dark burgundy powder (98 mg, 98%). 
Preparation of N-Propargylisatin 
To a solution of isatin (147 mg, 1.00 mmol) in dry DMF (40 mL) was added cesium carbonate (650 
mg, 2.00 mmol). The resulting brown suspension was stirred at 80-85 ºC for 30 min and then propargyl 
bromide (119 mg, 1.00 mmol) was added under a N2 atmosphere. The resulting mixture was stirred at 
80-85 ºC for 30 min, poured into ice water and the suspension partitioned between CH2Cl2 (20 mL) and 
water (20 mL). The aqueous layer was washed with CH2Cl2 (4×5 mL), and the combined organic 
layers washed with water (3×10 mL), dried (MgSO4) and concentrated. The residue was recrystallized 
from chloroform/hexane (1:6) to give N-propargylisatin (133 mg, 91%) as an orange solid. 1H NMR 
(CDCl3) δ 2.32 (2H, d, J = 1.7 Hz, H3'), 4.54 (2H, d, J = 1.9, H1'), 7.16 (2H, m, H5, H7), 7.66 (2H, m, 
H4, H6). 13C NMR (CDCl3) δ 29.8 (C3'), 73.7 (C2'), 76.0 (C1'), 111.4 (C7), 118.0 (C3a), 124.5 (C5), 
125.8 (C4), 138.8 (C6), 149.9 (C7a), 157.5 (C2), 182.9 (C3). MS (EI) m/z 185 (85%, M+), 129 (100%) 
consistent with literature values.21 
Antiplasmodial Assay  
The compounds and extracts were tested in vitro against Plasmodium falciparum, K1CB1 (K1), which 
is a multidrug resistant (chloroquine and antifolate resistant) strain, received as a generous gift from 
Professor Sodsri Thaithong, Chulalongkorn University, Bangkok, Thailand. The parasites were 
maintained in human red-blood cells in RPMI 1640 medium supplemented with 25 mM HEPES, 0.2% 
sodium bicarbonate and 8% human serum, at 37 ºC in a 3% carbon dioxide gas incubator (Trager and 
Jensen, 1976). Samples were made up in DMSO solution and the in vitro antimalarial activity testing 
was carried out using the microdilution radioisotope technique. The test sample (25 L, in the culture 
medium) was placed in triplicate in a 96-well plate where parasitized erythrocytes (200 L) with a cell 
suspension (1.5%) of parasitemia (0.5–1%) were then added to the wells. The ranges of the final 
concentrations of the samples were varied from 2 × 10-5 to 1 × 10-7 M with 0.1% of the organic solvent. 
The plates were then cultured under standard conditions for 24 h after which 3H-hypoxanthine (25 L, 
0.5 mCi) was added. The culture was incubated for 18–20 h after which the DNA from the parasite was 
harvested from the culture onto glass fibre filters and a liquid scintillation counter used to determine the 
amount of 3H-hypoxanthine incorporation.22 The inhibitory concentration of the sample was 
determined from its dose-response curves or by calculation. 
Cancer Growth Inhibition and Vero Cell Toxicity Assay  
Cancer growth inhibition assay and the Vero cell assay were performed using the Resazurin microplate 
assay (REMA) Method as described by O’Brien et al.23 In brief, cells at a logarithmic growth phase 
were harvested and diluted to 2.2×104 cells/mL for KB and 3.3×104 cells/mL for NCI-H187, in fresh 
medium. Successively, 5 µl of test sample diluted in 5% DMSO, and 45 µl of cell suspension were 
added to 384-well plates, incubated at 37 °C in 5% CO2 incubator. After the incubation period (3 days 
for KB, and 5 days for NCI-H187), 12.5 µl of 62.5 µg/mL resazurin solution was added to each and the 
plates were then incubated at 37 °C for 4 hours. Fluorescence signal was measured using SpectraMax 
M5 multi-detection microplate reader (Molecular Devices, USA) at the excitation and emission 
wavelengths of 530 nm and 590 nm. Percent inhibition of cell growth was calculated by the following 
equation: % Inhibition = [1- (FUT/ FUC)]×100 whereas FUT and FUC are the mean fluorescent unit 
from treated and untreated conditions, respectively. Dose response curves were plotted from 6 
concentrations of 3-fold serially diluted test compounds and the sample concentrations that inhibit cell 
growth by 50% (IC50) been derived using the SOFTMax Pro software (Molecular Devices, USA). 




Copies of 1H and 13C NMR for compounds 4 - 8 and UV-vis spectra for compounds 4 - 7, ORTEP plots 
and CIF files for 6, 7, and 8, images of fluorescence emission for 7 and 8, and a computed model for 5. 
This material is available free of charge via the Internet at http://pubs.acs.org. 
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Crystallographic Data for Compounds 6, 7 and 8 
 
Compound 6: C25H16N2O2, M = 376.41, T = 200 K, monoclinic, space group P21/n, Z = 4, a = 
8.4251(2), b = 10.9245(3), c = 20.7242(4) Å,  = 100.7475(15) °; V = 1874.00(8) Å3, Dx = 1.334 g 
cm–3, 4284 unique data (2max = 50 °), R = 0.039 [for 3584 reflections with I > 2.0(I)]; Rw = 0.104 
(all data), S = 0.99. 
 
Compound 7: C25H16N2O2, M = 376.41, T = 200 K, monoclinic, space group P21/n, Z = 4, a = 
8.8893(2), b = 21.6743(3), c = 10.0894(4) Å,  = 106.0180(9) °; V = 1868.45(7) Å3, Dx = 1.338 g 
cm–3, 4287 unique data (2max = 50 °), R = 0.040 [for 3143 reflections with I > 2.0(I)]; Rw = 0.098 
(all data), S = 0.96. 
 
Compound 8: C29H18N2O2, M = 458.47, T = 200 K, triclinic, space group P-1, Z = 2, a = 7.5927(2), 
b = 9.4172(3), c = 16.2992(4) Å,  = 76.3835(14),  = 88.6282(18),  = 78.0391(19) °; V = 
1107.70(6) Å3, Dx = 1.375 g cm
–3, 5070 unique data (2max = 50 °), R = 0.046 [for 4074 reflections 
with I > 2.0(I)]; Rw = 0.125 (all data), S = 0.99. 
 
Structure Determination 
Images were measured on a Nonius Kappa CCD diffractometer (MoKa, graphite monochromator,  
= 0.71073 Å) and data extracted using the DENZO package.1 Structure solution was by direct 
methods (SIR92).2 The structures of compounds 6, 7 and 8 were refined using the CRYSTALS 
program package.3 Atomic coordinates, bond lengths and angles, and displacement parameters for 
compounds  6, 7 and 8 have been deposited at the Cambridge Crystallographic Data Centre (CCDC 
nos. 932222, 932223 and 932224, respectively). These data can be obtained free-of-charge via 
www.ccdc.cam.ac.uk/data_request/cif, by emailing data_request@ccdc.cam.ac.uk, or by contacting 







Figure S1: Structure of compound 6 with labeling of selected atoms. Anisotropic displacement 
ellipsoids show 30% probability levels. Hydrogen atoms are drawn as circles with small radii. 
 
 
Figure S2: Structure of compound 7 with labeling of selected atoms. Anisotropic displacement 





Figure S3: Structure of compound 8 with labeling of selected atoms. Anisotropic displacement 


















Figure S5: Modeling for the position of the hydrogen atoms of the endo cyclic methylene and the 
exocyclic methylene in 5 with Spartan 10, Geometry Optimised, 6-31G (D) Level.  
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